Ajanta Pharma Ltd.
BSE: 532331 | Sector: Health care |
NSE: AJANTPHARM | ISIN Code: INE031B01049 |
BSE 00:00 | 20 May | 1733.35 |
28.00 (1.64%) |
OPEN
1714.15 |
HIGH
1737.35 |
LOW
1701.75 |
NSE 00:00 | 20 May | 1734.55 |
28.05 (1.64%) |
OPEN
1715.50 |
HIGH
1739.00 |
LOW
1701.00 |
OPEN | 1714.15 |
PREVIOUS CLOSE | 1705.35 |
VOLUME | 1449 |
52-Week high | 2420.00 |
52-Week low | 1593.30 |
P/E | 20.57 |
Mkt Cap.(Rs cr) | 14,803 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Ajanta Pharma Ltd. (AJANTPHARM) - Half Yearly Result
Particulars (![]() |
Mar '22 | Sep '21 | Mar '21 | Sep '20 | Mar '20 |
Net Sales/Income From Operations | 1574.21 | 1566.43 | 1481.23 | 1237.36 | 1091.23 |
Other Income | 56.32 | 83.41 | 4.23 | 99.34 | 105.27 |
Total Income | 1630.53 | 1649.84 | 1485.46 | 1336.70 | 1196.50 |
Total Expenditure | 1149.19 | 1100.56 | 988.59 | 813.09 | 849.95 |
Operating Profit | 481.34 | 549.28 | 496.87 | 523.61 | 346.55 |
Interest | 7.88 | 1.24 | 4.35 | 2.55 | 3.77 |
Gross Profit | 473.46 | 548.04 | 492.52 | 521.06 | 342.78 |
Depreciation | 60.80 | 60.16 | 57.43 | 54.06 | 47.39 |
PBT | 412.66 | 487.88 | 435.09 | 467.00 | 295.39 |
Tax | 79.94 | 91.23 | 104.46 | 112.22 | 103.94 |
Net Profit/(Loss) | 329.55 | 390.31 | 334.73 | 340.91 | 196.83 |
Minority Interest After NP | - | - | - | - | - |
Net Profit after Minority Interest | - | - | - | - | - |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | -2.85 |
Profit After Exceptional Items | 329.55 | 390.31 | 334.73 | 340.91 | 199.68 |
Equity Share Capital | 17.17 | 17.39 | 17.39 | 17.54 | 17.54 |
Reserves Excluding Revaluation Reserves | 0.00 | 3257.39 | 0.00 | 2783.74 | 0.00 |
EPS | |||||
Basic EPS | 38.39 | 45.11 | 38.50 | 39.07 | 22.44 |
Public Share Holding | |||||
No Of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
Share Holding (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Promoters and Promoter Group Shareholding | |||||
a) Pledged/Encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of Shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of Shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
b) Non-encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Note : | PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure. |
Quick Links for Ajanta Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices